Skip to content

Effectiveness of Telemedicine Care Replacing Standard Care in Gestational Diabetes

Effectiveness of Telemedicine Care Replacing Standard Care in Gestational Diabetes: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05521893
Enrollment
105
Registered
2022-08-30
Start date
2020-03-12
Completion date
2021-10-31
Last updated
2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes

Keywords

telemedicine, glycemic control, perinatal outcomes

Brief summary

This is a a single-centre, parallel, randomized controlled trial in women with gestational diabetes mellitus (GDM). Women are randomized to routine monthly prenatal clinic care (standard care group) or a group sending daily glucose readings via an application installed on a smartphone and monthly individual videoconferences replacing in-person visits (telemedicine group). The overall aim is to compare the effectiveness of the combine synchronous and asynchronous telemedicine care with the standard care in women with GDM.

Detailed description

In our single-centre, parallel, randomized controlled trial in women with gestational diabetes (GDM) the investigators aim to compare the effectiveness of combined synchonous and asynchronous telemedicine care with the standard care. In the telemedicine group appointments are performed online via monthly scheduled videoconferences. Women also receive a smartphone with the installed application that enable transfer of the measured capillary glucose concetration at the same time it is performed. The glucose data sent by women are reviewed once per week and after that healthcare professionals contact women if necessary. On the other hand, in the standard care group, visits are scheduled normally on a monthly basis at the diabetes clinic. Intention-to-treat analysis is going to be performed. The investigators aim to compare glycemic control, gestational weight gain and perinatal data between groups. Student's t-test or Mann-Whitney U test will be used for normally or non-normally distributed variables. Differences between groups in categorical data will be calcuated by Chi square.

Interventions

In the telemedicine group, the appointments are performed online via scheduled videoconferences, on a monthly basis. All women in the telemedicine group receive a smartphone with the installed application that enable transfer of the measured capillary glucose concentration.

OTHERStandard care

In the standard care group, visits are scheduled at the diabetes clinic on a monthly basis.

Sponsors

University Medical Centre Ljubljana
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* less then 30 weeks of gestation at enrolement * GDM diagnosis * at least moderate Slovenian language skills * willingness to participate

Exclusion criteria

* more than 30 weeks of pregnancy * overt diabetes or fasting glucose \>6.9 mmol/l at diagnosis * multiple pregnancy * poor Slovene language skills * history or bariatric surgery or other surgeries that induce malabsorbtion * use of systemic steroids prior to enrolment * presence of concomitant disease that could affect glucose control or self-management (e.g. uncontrolled psychiatric disorder)

Design outcomes

Primary

MeasureTime frameDescription
Average fasting glucose concentration1 monthAverage fasting based on participant's SMBG in the 3rd trimester
Percentage of glucose readings in the target range1 monthaverage percentage for the 3rd trimester
Compliance with SMBG1 monthis defined as defined as the number of actual glucose measurements performed divided by the number of recommended glucose measurements\*100
The percentage of individuals needing insulin treatmentonce during pregnancy
Average postprandial glucose concentration1 monthAverage postprandial glucose based on participant's SMBG in the 3rd trimester

Secondary

MeasureTime frameDescription
Incidence of preeclampsiadelivery
gestational weight gainonce during pregnancyfrom pre-conception until labour
Incidence of caesarean sectiondelivery
Newborn birth weightdelivery
LGA incidencedelivery
Gestational age at birthdelivery
Preterm birthdelivery

Countries

Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026